“…Haemodialysis is the most commonly used therapy (more than 90%) in patients with ESRD (Ghods & Savaj, ). Currently, there are more than 13,000 dialysis patients in Iran and the rate of these patients increases yearly by 15%, among which 1,500 are dying from the complications of dialysis (Baraz‐Pardenjani, Mohammadi, & Boroumand, ; Shafipour, Jafari, Shafipour, & Nasiri, ). By increasing the access to dialysis, hundreds of thousands of patients with end‐stage renal failure have a chance to survive, although where this therapy fails to change the course of the disease and it is associated with many physical, psychological and social stresses (Hasanzadeh, Shamsoddini, Moonaghi, & Ebrahimzadeh, ).…”